Figure 2From: Role of CD8-positive cells in radioimmunotherapy utilizing 177Lu-mAbs in an immunocompetent rat colon carcinoma model Curve of metastatic disease. Fraction of rats with observed metastatic disease in RIT (solid line) and anti-CD8 + RIT group (dashed line) during the study period including results of autopsy at the end of the study. Day 0 = day for injection of 177Lu-DOTA-BR96 treatment.Back to article page